RxDoctor Payments Data

Payman Emmanuel, MD

Orthopedic Surgery · Culver City, CANPI 1831132422

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (43.3%), education and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Micromed Inc at 30.1% of the total. Reporting peaked in 2024 at $5,311 and has fallen 95.8% since, to $224 in 2025.

$12,753in general payments, 2019–2025

Across 48 payments — averaging $265.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Micromed Inc$4K
  • Spineart USA Inc$3K
  • Advanced Orthopaedic Solutions, Inc.$2K
  • Arthrex$1K
  • Saxum Surgical, Inc.$936
  • Conformis, Inc.$903
  • plus $2K from 10 others
$37,476in ownership & investment interests, 2019–2025

Across 5 payments — averaging $7495.24 each. An ownership or investment interest held by the physician or an immediate family member.

  • Amplify Surgical, Inc.$37K

What the payments were for

  • Speaking & faculty fees$5004%
  • Travel & lodging$5,51943%
  • Food & beverage$2,89523%
  • Education$3,84030%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,753 in reported general payments places this provider in the 85th percentile of 130 orthopedic surgery providers in California.

See all orthopedic surgery providers in California

Medicare billing

Part B allowed, 2024
$712,330
Medicare patients
190
Services billed
17,479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide37$35,418
ProliaDenosumab11$18,552
MounjaroTirzepatide12$12,225
Celecoxib32$490
Pregabalin32$297
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$213
Esomeprazole Magnesium13$183
Diclofenac Sodium ErDiclofenac Sodium12$105
Nabumetone12$94
Gabapentin13$88
Meloxicam26$78
Naproxen17$55
Diclofenac Sodium11$54
Cephalexin18$46

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Culver City

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →